Development of Nanoparticle Drug-Delivery Systems for The Inner Ear

References

• Kim DK , ParkSN, ParkKHet al. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles. Drug Deliv.22(3), 367–374 (2015).
   PubMed Web of Science ®Google Scholar
• Kim DK . Nanomedicine for inner ear diseases: a review of recent in vivo studies. Biomed. Res. Int.2017(6), 1–6 (2017).
   Google Scholar
• Mittal R , PatelAP, NguyenDet al. Genetic basis of hearing loss in Spanish, Hispanic and Latino populations. Gene647, 297–305 (2018).
   PubMed Web of Science ®Google Scholar
• Cunningham LL , TucciDL. Hearing loss in adults. N. Engl. J. Med.377(25), 2465–2473 (2017).
   PubMed Web of Science ®Google Scholar
• Nieman CL , ReedNS, LinFR. Otolaryngology for the internist: hearing loss. Med. Clin. N. Am.102(6), 977–992 (2018).
   PubMed Web of Science ®Google Scholar
• Eshraghi AA , JungHD, MittalR. Recent advancements in gene and stem cell-based treatment modalities: potential implications in noise-induced hearing loss. Anat. Rec. (Hoboken)303(3), 516–526 (2019).
   PubMedGoogle Scholar
• Mittal R , PenaSA, ZhuAet al. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artif. Cells Nanomed. Biotechnol.47(1), (2019).
   Web of Science ®Google Scholar
• World Health Organisation . Deafness and hearing loss (2020). www.who.int/en/news-room/fact-sheets/detail/deafness-and-hearing-loss
   Google Scholar
• Eshraghi AA , NazarianR, TelischiFF, RajguruSM, TruyE, GuptaC. The cochlear implant: historical aspects and future prospects. Anat. Rec.(Hoboken)295(11), 1967–1980 (2012).
   PubMedGoogle Scholar
• Roche JP , HansenMR. On the horizon: cochlear implant technology. Otolaryngol. Clin. N. Am.48(6), 1097–1116 (2015).
   PubMed Web of Science ®Google Scholar
• Kayyali MN , WooltortonJRA, RamseyAJet al. A novel nanoparticle delivery system for targeted therapy of noise-induced hearing loss. J. Control. Rel.279, 243–250 (2018).
   PubMed Web of Science ®Google Scholar
• Pyykkö I , ZouJ, Schrott-FischerA, GluekertR, KinnunenP. An overview of nanoparticle based delivery for treatment of inner ear disorders. Methods Mol. Biol.1427, 363–415 (2016).
   PubMedGoogle Scholar
• Mittal R , PatelAP, JhaveriVMet al. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opin. Drug Deliv.15(3), 301–318 (2018).
   PubMed Web of Science ®Google Scholar
• Mittal R , JhaveriVM, McMurryHSet al. Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine. Artif. Cells Nanomed. Biotechnol.46(Suppl. 1), 831–840 (2018).
   PubMedGoogle Scholar
• Schwander M , KacharB, MüllerU. The cell biology of hearing. J. Cell Biol.190(1), 9–20 (2010).
   PubMed Web of Science ®Google Scholar
• Fettiplace R , HackneyCM. The sensory and motor roles of auditory hair cells. Nat. Rev. Neurosci.7(1), 19–29 (2006).
   PubMed Web of Science ®Google Scholar
• Hudspeth A . Integrating the active process of hair cells with cochlear function. Nat. Rev. Neurosci.15(9), 600 (2014).
   PubMed Web of Science ®Google Scholar
• Nyberg S , AbbottNJ, ShiX, SteygerPS, DabdoubA. Delivery of therapeutics to the inner ear: the challenge of the blood–labyrinth barrier. Sci. Transl. Med.11(482), eaao0935 (2019).
   PubMed Web of Science ®Google Scholar
• Cohen-Salmon M , RegnaultB, CayetNet al. Connexin30 deficiency causes instrastrial fluid–blood barrier disruption within the cochlear stria vascularis. Proc. Natl Acad. Sci. USA104(15), 6229–6234 (2007).
   PubMed Web of Science ®Google Scholar
• Shi Xiaorui . Pathophysiology of the cochlear intrastrial fluid–blood barrier (review). Hear. Res.338, 52–63 (2016).
   PubMed Web of Science ®Google Scholar
• Kitajiri SI . Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential. J. Cell Sci.117(21), 5087–5096 (2004).
   PubMed Web of Science ®Google Scholar
• Florian P , AmashehS, LessidrenskyMet al. Claudins in the tight junctions of stria vascularis marginal cells. Biochem. Biophys. Res. Commun.304(1), 5–10 (2003).
   PubMed Web of Science ®Google Scholar
• Steel KP , BarkwayC. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development107(3), 453–463 (1989).
   PubMed Web of Science ®Google Scholar
• Wu Y-X , ZhuG-X, LiuX-Qet al. Noise alters guinea pig’s blood–labyrinth barrier ultrastructure and permeability along with a decrease of cochlear claudin-5 and occludin. BMC Neurosci.15(1), 136 (2014).
   PubMedGoogle Scholar
• Steven KJ , LeonardPR, LFW. Transport characteristics of the blood–perilymph barrier. Am. J. Otolaryngol.3(6), 392–396 (1982).
   PubMed Web of Science ®Google Scholar
• Gang C , XiaoZ, FanY, LeiM. Disposition of nanoparticle-based delivery system via inner ear administration. Curr. Drug Metab.11(10), 886–897 (2010).
   PubMed Web of Science ®Google Scholar
• Fowler EP . Streptomycin treatment of vertigo. Trans. Am. Acad. Ophthalmol. Otolaryngol.52, 293 (1948).
   PubMedGoogle Scholar
• Graham MD , SataloffRT, KeminkJL. Titration streptomycin therapy for bilateral Meniere’s disease: a preliminary report. Otolaryngol. Head Neck Surg.92(4), 440–447 (1984).
   PubMed Web of Science ®Google Scholar
• Ruckenstein MJ . Autoimmune inner ear disease. Otolaryngol. Head Neck Surg.112(5), 171–174 (2004).
   Google Scholar
• Yoda S , CureogluS, ShimizuSet al. Round window membrane in Ménière’s disease: a human temporal bone study. Otol. Neurotol.32(1), 147–151 (2015).
   Google Scholar
• Okuda T , SugaharaK, ShimogoriH, YamashitaH. Inner ear changes with intracochlear gentamicin administration in guinea pigs. Laryngoscope114(4), 694–697 (2009).
   Google Scholar
• Salt AN , PlontkeSKR. Local inner-ear drug delivery and pharmacokinetics. Drug Discov. Today10(19), 1299–1306 (2005).
   PubMed Web of Science ®Google Scholar
• Plontke SK , MikulecAA, SaltAN. Rapid clearance of methylprednisolone after intratympanic application in humans. Comment on: Bird PA, Begg EJ, Zhang M et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol. Neurotol. 28, 1124–1130 (2007). Otol. Neurotol.29(5), 732–733 (2008).
   PubMed Web of Science ®Google Scholar
• Barrs DM , KeyserJS, StallworthC, McElveenJTJr. Intratympanic steroid injections for intractable Meniere’s disease. Laryngoscope111(12), 2100–2104 (2001).
   PubMed Web of Science ®Google Scholar
• Plontke SK , LöwenheimH, MertensJet al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope119(2), 359–369 (2009).
   PubMed Web of Science ®Google Scholar
• Yang KJ , SonJ, JungSYet al. Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy. Biomaterials171, 133–143 (2018).
   PubMed Web of Science ®Google Scholar
• Pyykkö I , ZouJ, ZhangW, ZhangY. Nanoparticle-based delivery for the treatment of inner ear disorders. Curr. Opin. Otolaryngol. Head Neck Surg.19(5), 388–396 (2011).
   PubMed Web of Science ®Google Scholar
• Jero J , MhatreAN, TsengCJet al. Cochlear gene delivery through an intact round window membrane in mouse. Hum. Gene Ther.12(5), 539–548 (2001).
   PubMed Web of Science ®Google Scholar
• Staecker H , LiD, O’MalleyBW, VandeWater TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol.121(2), 157–163 (2001).
   PubMed Web of Science ®Google Scholar
• Zheng F , ShiXW, YangGFet al. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci.80(4), 388–396 (2007).
   PubMed Web of Science ®Google Scholar
• Surovtseva EV , JohnstonAH, ZhangWet al. Prestin binding peptides as ligands for targeted polymersome mediated drug delivery to outer hair cells in the inner ear. Int. J. Pharm.424(1–2), 121–127 (2012).
   PubMedGoogle Scholar
• Zhang Y , ZhangW, JohnstonAH, NewmanTA, PyykköI, ZouJ. Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve. Int. J. Nanomedicine7, 1015–1022 (2012).
   PubMed Web of Science ®Google Scholar
• Youm I , YouanBB. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines. Hear. Res.304, 7–19 (2013).
   PubMed Web of Science ®Google Scholar
• Paulson DP , AbuzeidW, JiangH, OeT, O’MalleyBW, LiD. A novel controlled local drug delivery system for inner ear disease. Laryngoscope118(4), 706–711 (2008).
   PubMed Web of Science ®Google Scholar
• Xu L , HeldrichJ, WangHet al. A controlled and sustained local gentamicin delivery system for inner ear applications. Otol. Neurotol.31(7), 1115–1121 (2010).
   PubMed Web of Science ®Google Scholar
• Lajud SA , HanZ, ChiF-Let al. A regulated delivery system for inner ear drug application. J. Control. Rel.166(3), 268–276 (2013).
   PubMed Web of Science ®Google Scholar
• Lajud SA , NagdaDA, QiaoPet al. A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application. Otol. Neurotol.36(2), 341–347 (2015).
   PubMed Web of Science ®Google Scholar
• Sun C , WangX, ChenD, LinX, YuD, WuH. Dexamethasone loaded nanoparticles exert protective effects against cisplatin-induced hearing loss by systemic administration. Neurosci. Lett.619, 142–148 (2016).
   PubMed Web of Science ®Google Scholar
• Sakamoto T , NakagawaT, HorieRTet al. Inner ear drug delivery system from the clinical point of view. Acta Otolaryngol. Suppl.563, 101–104 (2010).
   Google Scholar
• Husseman J , RaphaelY. Gene therapy in the inner ear using adenovirus vectors. In: Gene Therapy of Cochlear Deafness. RyanAF ( Ed.). Karger AG, Basel, Switzerland, 37–51 (2009).
   Google Scholar
• Chen WT , LeeJW, YuanCH, ChenRF. Oral steroid treatment for idiopathic sudden sensorineural hearing loss. Saudi Med. J.36(3), 291 (2015).
   PubMed Web of Science ®Google Scholar
• Filipo R , AttanasioG, RussoFYet al. Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss. Audiol. Neurotol.19(4), 225–233 (2014).
   PubMed Web of Science ®Google Scholar
• Parnes LS , SunAH, FreemanDJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope109(S91), 1–17 (2010).
   Google Scholar
• Yuan Fang QW . Development of drug delivery to inner ear. Chinese J. Otol.4, 575–580 (2018).
   Google Scholar
• Schuknecht HF . Ablation therapy in the management of Meniere’s disease. Acta Otolaryngol.132, 1–42 (1957).
   Google Scholar
• Pyykkö I , ZouJ, Schrott-FischerA, GlueckertR, KinnunenP. An overview of nanoparticle based delivery for treatment of inner ear disorders. Methods Mol. Biol.1427, 363–415 (2016).
   PubMedGoogle Scholar
• Bangham AD , StandishMM, WatkinsJC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol.13(1), 238–252 (1965).
   PubMed Web of Science ®Google Scholar
• Gregoriadis G , RymanBE. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem. J.124(5), 58P (1971).
   PubMed Web of Science ®Google Scholar
• Marty JJ , OppenheimRC, SpeiserP. Nanoparticles – a new colloidal drug delivery system. Pharm. Acta Helv.53(1), 17–23 (1978).
   PubMedGoogle Scholar
• Kreuter J . Nanoparticles and nanocapsules – new dosage forms in the nanometer size range. Pharm. Acta Helv.53(2), 33–39 (1978).
   PubMedGoogle Scholar
• Couvreur P , KanteB, RolandM, SpeiserP. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. J. Pharm. Sci.68(12), 1521–1524 (1979).
   PubMed Web of Science ®Google Scholar
• Pritz CO , DudásJ, Rask-AndersenH, Schrott-FischerA, GlueckertR. Nanomedicine strategies for drug delivery to the ear. Nanomedicine (Lond.)8(7), 1155–1172 (2013).
   PubMed Web of Science ®Google Scholar
• Roy S , JohnstonAH, NewmanTAet al. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Int. J. Pharm.390(2), 214–224 (2010).
   PubMedGoogle Scholar
• Du X , ChenK, KuriyavarSet al. Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs. Otol. Neurotol.34(1), 41–47 (2013).
   PubMed Web of Science ®Google Scholar
• Lundman L , Bagger-SjöbäckD, HolmquistL, JuhnS. Round window membrane permeability: an in vitro model. Acta Otolaryngol.104(Suppl. 442), 41–43 (1987).
   Google Scholar
• Liu H , ChenS, ZhouYet al. The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution. J. Drug Target.21(9), 846–854 (2013).
   PubMed Web of Science ®Google Scholar
• Smith BM , MyersMG. The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol. Head Neck Surg.87(6), 888 (1979).
   PubMed Web of Science ®Google Scholar
• Zhang Y , SuH, WenL, YangF, ChenG. Mathematical modeling for local trans-round window membrane drug transport in the inner ear. Drug Deliv.23(8), 1 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhangW, LoblerMet al. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int. J. Pharm.404(1–2), 211–219 (2011).
   PubMedGoogle Scholar
• Cai H , LiangZ, HuangW, WenL, ChenG. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Int. J. Pharm.532(1), 55–65 (2017).
   PubMedGoogle Scholar
• Zhang L , XuY, CaoW, XieS, WenL, ChenG. Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine. Int. J. Nanomedicine13, 479–492 (2018).
   PubMed Web of Science ®Google Scholar
• King EB , SaltAN, EastwoodHT, O’LearySJ. Direct entry of gadolinium into the vestibule following intratympanic applications in Guinea pigs and the influence of cochlear implantation. J. Assoc. Res. Otolaryngol.12(6), 741–751 (2011).
   PubMed Web of Science ®Google Scholar
• King EB , SaltAN, KelGE, EastwoodHT, O’LearySJ. Gentamicin administration on the stapes footplate causes greater hearing loss and vestibulotoxicity than round window administration in guinea pigs. Hear. Res.304(10), 159–166 (2013).
   PubMedGoogle Scholar
• Zou J , PoeD, RamadanUA, PyykköI. Oval window transport of Gd-dOTA from rat middle ear to vestibulum and scala vestibuli visualized by in vivo magnetic resonance imaging. Ann. Otol. Rhinol. Laryngol.121(2), 119–128 (2012).
   PubMed Web of Science ®Google Scholar
• Zou J , PyykkoIB, DastidarP, ToppilaE. Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI. Audiol. Neurootol.10(3), 145–152 (2005).
   PubMed Web of Science ®Google Scholar
• Ding S , XieS, ChenWet al. Is oval window transport a royal gate for nanoparticle delivery to vestibule in the inner ear? Eur. J. Pharm. Sci. 126, 11–22 (2018).
   PubMed Web of Science ®Google Scholar
• Praetorius GT , BrunnerC, LehnertBet al. Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol.127(5), 486–490 (2007).
   PubMed Web of Science ®Google Scholar
• Kneuer C , SametiM, BakowskyUet al. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug. Chem.11(6), 926–932 (2000).
   PubMed Web of Science ®Google Scholar
• Sameti M , BohrG, RaviKumar MNet al. Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int. J. Pharm.266(1–2), 51–60 (2003).
   PubMed Web of Science ®Google Scholar
• Wang Y , WiseAK, TanJ, MainaJW, ShepherdRK, CarusoF. Mesoporous silica supraparticles for sustained inner-ear drug delivery. Small10(21), 4244–4248 (2014).
   PubMed Web of Science ®Google Scholar
• Gluekert R , PritzCO, RoyS, DudasJ, Schrott-FischerA. Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies. Front. Aging Neurosci.7, 71 (2015).
   PubMed Web of Science ®Google Scholar
• Wang Y , WiseAK, TanJ, MainaJW, ShepherdRK, CarusoF. Mesoporous silica supraparticles for sustained inner-ear drug delivery. Small10(21), 4244–4248 (2014).
   PubMed Web of Science ®Google Scholar
• Pritz CO , BitscheM, SalvenmoserW, DudásJ, Schrott-FischerA, GlueckertR. Endocytic trafficking of silica nanoparticles in a cell line derived from the organ of Corti. Nanomedicine (Lond.)8(2), 239–252 (2012).
   PubMed Web of Science ®Google Scholar
• Praetorius M , BrunnerC, LehnertBet al. Transsynaptic delivery of nanoparticles to the central auditory nervous system. Acta Otolaryngol.127(5), 486–490 (2007).
   PubMed Web of Science ®Google Scholar
• Champagne PO , WestwickH, BouthillierA, SawanM. Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review. Nanomedicine (Lond.)13(11), 1385–1400 (2018).
   PubMed Web of Science ®Google Scholar
• Wahajuddin , AroraS. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int. J. Nanomedicine7, 3445–3471 (2012).
   PubMed Web of Science ®Google Scholar
• Mondalek FG , ZhangYY, KroppBet al. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J. Nanobiotechnol.4(1), 4 (2006).
   PubMedGoogle Scholar
• Barnes AL , WasselRA, MondalekF, ChenK, DormerKJ, KopkeRD. Magnetic characterization of superparamagnetic nanoparticles pulled through model membranes. Biomagn. Res. Technol.5(1), 1 (2007).
   PubMedGoogle Scholar
• Zou J , ZhangW, PoeDet al. MRI manifestation of novel superparamagnetic iron oxide nanoparticles in the rat inner ear. Nanomedicine (Lond.)5(5), 739–754 (2010).
   PubMed Web of Science ®Google Scholar
• Kopke RD , WasselR, MondalekFet al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol. Neurootol.11(2), 123–133 (2006).
   PubMed Web of Science ®Google Scholar
• Dormer KJ , AwasthiV, GalbraithW, KopkeRD, ChenK, WasselR. Magnetically-targeted, technetium 99m-labeled nanoparticles to the inner ear. J. Biomed. Nanotechnol.4(2), 174–184 (2008).
   Web of Science ®Google Scholar
• Dormer K , SmithN, KopkeRet al. Feasibility of superparamagnetic nanoparticles for drug delivery to the inner ear. In: Technical Proceedings of the 2005 NSTI Nanotechnology Conference and Trade Show, Volume 1. 132–135 (2005). https://briefs.techconnect.org/wp-content/volumes/Nanotech2005v1/pdf/1093.pdf
   Google Scholar
• Rd K , RaW, FMet al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol. Neurootol.11(2), 123–133 (2006).
   PubMed Web of Science ®Google Scholar
• Nguyen Y , CelerierC, PszczolinskiRet al. Superparamagnetic nanoparticles as vectors for inner ear treatments: driving and toxicity evaluation. Acta Otolaryngol.136(4), 402–408 (2016).
   PubMed Web of Science ®Google Scholar
• Watada Y , YamashitaD, ToyodaMet al. Magnetic resonance monitoring of superparamagnetic iron oxide (SPIO)-labeled stem cells transplanted into the inner ear. Neurosci. Res.95, 21–26 (2015).
   PubMed Web of Science ®Google Scholar
• Du X , ChenK, KuriyavarSet al. Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs. Otol. Neurotol.34(1), 41–47 (2013).
   PubMed Web of Science ®Google Scholar
• Mondalek FG , ZhangYY, KroppBet al. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J. Nanobiotechnol.4, 4 (2006).
   PubMedGoogle Scholar
• Chen G , HouSX, HuP, JinMZ, LiuJ. [Preliminary study on brain-targeted drug delivery via inner ear]. Yao Xue Xue Bao42(10), 1102–1106 (2007).
   PubMedGoogle Scholar
• Zou J , SaulnierP, PerrierTet al. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J. Biomed. Mater. Res. B Appl. Biomater.87B(1), 10–18 (2008).
   Web of Science ®Google Scholar
• Scheper V , WolfM, SchollMet al. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond.)4(6), 623–635 (2009).
   PubMed Web of Science ®Google Scholar
• Chen G , HouSX, HuP, HuQH, GuoDD, XiaoY. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. Nan Fang Yi Ke Da Xue Xue Bao28(6), 1022–1024 (2008).
   PubMedGoogle Scholar
• Roy S , GluekertR, JohnstonAHet al. Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Nanomedicine (Lond.)7(1), 55–63 (2012).
   PubMed Web of Science ®Google Scholar
• Wareing M , MhatreAN, PettisRet al. Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear. Res.128(1–2), 61–69 (1999).
   PubMed Web of Science ®Google Scholar
• Staecker H , LiD, O’MalleyBW, VanDe Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol.121(2), 157–163 (2001).
   PubMed Web of Science ®Google Scholar
• Jero J , TsengCJ, MhatreAN, LalwaniAK. A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear. Res.151(1–2), 106–114 (2001).
   PubMed Web of Science ®Google Scholar
• Zylberberg C , GaskillK, PasleyS, MatosevicS. Engineering liposomal nanoparticles for targeted gene therapy. Gene Ther.24, 441 (2017).
   PubMed Web of Science ®Google Scholar
• Panahi Y , FarshbafM, MohammadhosseiniMet al. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications. Artif. Cells Nanomed. Biotechnol.45(4), 788–799 (2017).
   PubMed Web of Science ®Google Scholar
• Maeda Y , FukushimaK, KawasakiA, NishizakiK, SmithRJH. Cochlear expression of a dominant-negative GJB2R75W construct delivered through the round window membrane in mice. Neurosci. Res.58(3), 250–254 (2007).
   PubMed Web of Science ®Google Scholar
• Buckiova D , RanjanS, NewmanTAet al. Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane. Nanomedicine (Lond.)7(9), 1339–1354 (2012).
   PubMed Web of Science ®Google Scholar
• Roy S , JohnstonAH, NewmanTAet al. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Int. J. Pharm.390(2), 214–224 (2010).
   PubMedGoogle Scholar
• Mittal R , PenaSA, ZhuAet al. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artif. Cells Nanomed. Biotechnol.47(1), 1312–1320 (2019).
   PubMed Web of Science ®Google Scholar
• Veronese FM , MeroA. The impact of PEGylation on biological therapies. BioDrugs22(5), 315–329 (2008).
   PubMed Web of Science ®Google Scholar
• Ge X , JacksonRL, LiuJet al. Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol. Head Neck Surg.137(4), 619–623 (2007).
   PubMed Web of Science ®Google Scholar
• Tamura T , KitaT, NagagawaTet al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope115(11), 2000–2005 (2005).
   PubMed Web of Science ®Google Scholar
• Ge X , JacksonRL, LiuJet al. Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol. Head Neck Surg.137(4), 619–623 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang L , XuY, CaoW, XieS, WenL, ChenG. Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine. Int. J. Nanomedicine13, 479–492 (2018).
   PubMed Web of Science ®Google Scholar
• Du X , CaiQ, WestMBet al. Regeneration of cochlear hair cells and hearing recovery through hes1 modulation with siRNA nanoparticles in adult guinea pigs. Mol. Ther.26(5), 1313–1326 (2018).
   PubMed Web of Science ®Google Scholar
• Dai J , LongW, LiangZ, WenL, YangF, ChenG. A novel vehicle for local protein delivery to the inner ear: injectable and biodegradable thermosensitive hydrogel loaded with PLGA nanoparticles. Drug Dev. Indust. Pharm.44(1), 89–98 (2018).
   PubMed Web of Science ®Google Scholar
• Cai H , WenX, WenLet al. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration. Int. J. Nanomedicine9, 5591–5601 (2014).
   PubMed Web of Science ®Google Scholar
• Cai H , LiangZ, HuangW, WenL, ChenG. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Int. J. Pharm.532(1), 55–65 (2017).
   PubMedGoogle Scholar
• Lajud SA , NagdaDA, QiaoPet al. A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application. Otol. Neurotol.36(2), 341–347 (2015).
   PubMed Web of Science ®Google Scholar
• Paulson DP , AbuzeidW, JiangH, OeT, O’MalleyBW, LiD. A novel controlled local drug delivery system for inner ear disease. Laryngoscope118(4), 706–711 (2008).
   PubMed Web of Science ®Google Scholar
• Xu L , HeldrichJ, HaiboWet al. A controlled and sustained local gentamicin delivery system for inner ear applications. Otol. Neurotol.31(7), 1115–1121 (2010).
   PubMed Web of Science ®Google Scholar
• Luo J , XuL. Distribution of gentamicin in inner ear after local administration via a chitosan glycerophosphate hydrogel delivery system. Ann. Otol. Rhinol. Laryngol.121(3), 208–216 (2012).
   PubMed Web of Science ®Google Scholar
• Lafond JF , ShimojiM, RamaswamyBet al. Middle ear histopathology following magnetic delivery to the cochlea of prednisolone-loaded iron oxide nanoparticles in rats. Toxicol. Pathol.46(1), 101–106 (2018).
   PubMed Web of Science ®Google Scholar
• Mahmoudi M , SahraianMA, ShokrgozarMA, LaurentS. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. ACS Chem. Neurosci.2(3), 118–140 (2011).
   PubMed Web of Science ®Google Scholar
• Jalani G , NaccacheR, RosenzweigDH, HaglundL, VetroneF, CerrutiM. Photocleavable hydrogel coated upconverting nanoparticles: a multifunctional theranostic platform for NIR imaging and on-demand macromolecular delivery. J. Am. Chem. Soc.138(3), 1078 (2015).
   Web of Science ®Google Scholar
• Sun X , SunH, LiH, PengH. Developing polymer composite materials: carbon nanotubes or graphene?Adv. Mater.25(37), 5153–5176 (2013).
   PubMed Web of Science ®Google Scholar
• Merino S , MartínC, KostarelosK, PratoM, VázquezE. Nanocomposite hydrogels: 3D polymer–nanoparticle synergies for on-demand drug delivery. ACS Nano9(5), 4686–4697 (2015).
   PubMed Web of Science ®Google Scholar
• Shin SR , BaeH, ChaJMet al. Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano6(1), 362–372 (2012).
   PubMed Web of Science ®Google Scholar
• Basuki J , QieF, MuletXet al. Photo-modulated therapeutic protein release from a hydrogel depot using visible light. Angew. Chem.56(4), 966–971 (2017).
   Google Scholar
• Wang P , SunJ, LouZet al. Assembly-induced thermogenesis of gold nanoparticles in the presence of alternating magnetic field for controllable drug release of hydrogel. Adv. Mater.28(48), 10801 (2016).
   PubMed Web of Science ®Google Scholar
• Sun C , WangX, ChenD, LinX, YuD, WuH. Dexamethasone loaded nanoparticles exert protective effects against cisplatin-induced hearing loss by systemic administration. Neurosci. Lett.619, 142–148 (2016).
   PubMed Web of Science ®Google Scholar
• Martínsaldaña S , PalaosuayR, TrinidadA, AguilarMR, RamírezcamachoR, SanRJ. Otoprotective properties of 6α-methylprednisolone-loaded nanoparticles against cisplatin: in vitro and in vivo correlation. Nanomedicine12(4), 965–976 (2016).
   PubMed Web of Science ®Google Scholar
• Yoon JY , YangKJ, KimDEet al. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Biomaterials73, 243–253 (2015).
   PubMed Web of Science ®Google Scholar
• Gentilin E , SimoniE, CanditoM, CazzadorD, AstolfiL. Cisplatin-induced ototoxicity: updates on molecular targets. Trends Mol. Med.25(12), 1123–1132 (2019).
   PubMed Web of Science ®Google Scholar
• Mittal R , PenaSA, ZhuAet al. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artif. Cells Nanomed. Biotechnol.47(1), 1312–1320 (2019).
   PubMed Web of Science ®Google Scholar
• Rybak LP , MukherjeaD, RamkumarV. Mechanisms of cisplatin-induced ototoxicity and prevention. Semin. Hear.40(2), 197–204 (2019).
   PubMedGoogle Scholar
• Li L , ChaoT, BrantJ, O’MalleyB, TsourkasA, LiD. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss. Adv. Drug Deliv. Rev.108, 2–12 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou S , SunY, KuangXet al. Mitochondria-homing peptide functionalized nanoparticles performing dual extracellular/intracellular roles to inhibit aminoglycosides induced ototoxicity. Artif. Cells Nanomed. Biotechnol.46(Suppl. 2), 314–323 (2018).
   PubMedGoogle Scholar
• Zhou S , SunY, KuangXet al. Mitochondria-targeting nanomedicine: an effective and potent strategy against aminoglycosides-induced ototoxicity. Eur. J. Pharm. Sci.126, 59–68 (2019).
   PubMed Web of Science ®Google Scholar
• Wang X , ChenY, TaoY, GaoY, YuD, WuH. A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss. Int. J. Nanomedicine13, 7517–7531 (2018).
   PubMed Web of Science ®Google Scholar